| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 20.180 | 63.646 | 75.354 | 84.047 | 104.973 | 126.432 | 158.177 | 264.945 |
| Total Income - EUR | - | - | 20.180 | 63.646 | 75.354 | 84.306 | 104.986 | 126.454 | 158.790 | 265.962 |
| Total Expenses - EUR | - | - | 2.436 | 8.821 | 7.947 | 39.091 | 21.759 | 22.695 | 45.432 | 78.162 |
| Gross Profit/Loss - EUR | - | - | 17.744 | 54.825 | 67.406 | 45.215 | 83.227 | 103.759 | 113.358 | 187.800 |
| Net Profit/Loss - EUR | - | - | 17.143 | 52.921 | 65.146 | 43.771 | 82.207 | 102.520 | 111.802 | 181.015 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Fernye Clinica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 40.409 | 32.534 | 20.858 | 10.357 | 60.629 | 110.891 |
| Current Assets | - | - | 19.321 | 23.780 | 25.688 | 18.360 | 23.260 | 32.109 | 43.843 | 26.634 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 43 | 79 | 5.003 | 10.001 | 10.321 | 9.906 | 9.850 |
| Cash | - | - | 19.321 | 9.891 | 1.975 | 6.121 | 2.140 | 9.621 | 9.576 | 2.209 |
| Shareholders Funds | - | - | 53 | 52 | 51 | 50 | 49 | 49 | 49 | 48 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 19.269 | 23.729 | 66.046 | 50.844 | 44.069 | 42.417 | 104.423 | 137.477 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Fernye Clinica S.r.l.